Select Medical Holdings

Select Medical Holdings Corp. engages in the provision of medical rehabilitation services. It operates through the following segments: Critical Illness Recovery Hospital, Rehabilitation Hospital, Outpatient Rehabilitation and Concentra. The Critical Illness Recovery Hospital segment serves patients with debilitating injuries and rehabilitation needs that cannot be adequately cared in a medically intensive environment, such as a skilled nursing facility. The Rehabilitation Hospital segment provides physical medicine, as well as rehabilitation programs and services, which serve to optimize patient health, function, and quality of life. The Outpatient Rehabilitation segment provides physical, occupational, and speech rehabilitation services through its clinics. The Concentra segment operates through its medical centers and contract services provided at employer worksites and Department of Veterans Affairs community-based outpatient clinics, which deliver occupational medicine, physical therapy, veteran’s healthcare, and consumer health services. The company was founded by Robert A. Ortenzio and Rocco A. Ortenzio in 1996 and is headquartered in Mechanicsburg, PA.

Earnings data Q1 2021

Earnings data Q2 2021

Earnings data Q3 2021

Earnings data Q4 2021

Earnings data Q1 2022

Earnings data Q2 2022

Earnings data Q3 2022

Earnings data Q4 2022

Earnings data Q1 2023

Earnings data Q2 2023

Earnings data Q3 2023

Earnings data Q4 2023

Earnings data Q1 2024

Earnings data Q2 2024

Earnings data Q3 2024

Earnings data Q4 2024

Select Medical Holdings reports strong Q4 results and growth outlook

Select Medical Holdings demonstrated financial strength and growth potential in Q4 2022 across its divisions.
While challenges like labor market uncertainty persist, opportunities for revenue growth and strategic expansion are evident.
The company's focus on cost management and operational efficiency bodes well for future performance and stakeholder engagement.

Select Medical Holdings posts strong Q1 results, eyes growth

Select Medical Holdings (SEM) reported robust Q1 2023 results, showcasing growth across all divisions and a positive outlook for the year ahead.
The company's focus on cost management, strategic investments, and operational efficiency positions it well for continued success and market expansion.
While facing challenges such as revenue fluctuations and rising interest expenses, Select Medical Holdings remains proactive in addressing operational and financial hurdles.
Opportunities for growth through market expansion, technology utilization, and strategic initiatives underscore a promising trajectory for the company.

Select Medical Holdings reports strong Q2 performance and growth outlook

Select Medical Holdings (SEM) demonstrated robust financial performance in Q2 2023, driven by revenue growth and improved EBITDA across divisions.
The company's strategic refinancing and positive industry recognition position SEM well for future growth and operational excellence.
While facing challenges in maintaining exceptional growth rates, SEM has opportunities to capitalize on its strengths and market positioning for sustained success.

Select Medical Holdings (SEM) reports strong Q3 performance and expansion plans

Select Medical Holdings (SEM) demonstrated robust financial growth in Q3 2023, driven by improvements in various divisions.
The company's focus on expansion through new hospital openings and partnerships presents promising opportunities for future growth.
Overall, Select Medical Holdings (SEM) is well-positioned for continued success and value creation for its shareholders.

Select Medical Holdings reports strong Q4 results and growth opportunities

SEM's strong performance in Q4 2023 and strategic initiatives position the company for growth and value creation.
While facing challenges such as projected start-up losses and increased interest expenses, SEM is actively pursuing opportunities for financial optimization.
The company's focus on separating Concentra, expanding partnerships, and managing capital allocation underscores its commitment to enhancing shareholder value.
Investors should monitor SEM's progress in executing its 2024 outlook and addressing financial challenges to assess future performance.

Select Medical Holdings posts robust Q1 results and outlines growth plans

Select Medical Holdings (SEM) reported strong financial and operational performance in Q1 2024, driven by revenue growth, margin expansion, and strategic initiatives.
While facing challenges in working capital management and capital allocation decisions, SEM's focus on efficiency and growth presents opportunities for value creation and market expansion.
Investors should monitor SEM's progress in executing its growth plans, managing debt levels, and capitalizing on opportunities in the healthcare services sector.

Select Medical Holdings reports solid Q2 performance and expansion plans

Select Medical Holdings delivered a strong Q2 performance with revenue and EBITDA growth across key divisions.
The company's focus on expansion, quality healthcare services, and shareholder returns positions it well for future growth.
While facing challenges like earnings per share decline and regulatory changes, Select Medical has opportunities for market expansion and service enhancement.
Investors should monitor Concentra's performance details and the company's strategic execution in new hospital developments.

Select Medical Holdings reports strong Q3 performance and expansion plans

Select Medical Holdings delivered a robust performance in Q3, with strong revenue and EBITDA growth across all divisions.
The company's expansion plans and strategic projects indicate a focus on long-term growth and market presence.
While facing challenges in managing expansion and financing, Select Medical has opportunities to capitalize on sector growth and operational improvements.
Investors can be optimistic about Select Medical's financial health, demonstrated by the declared cash dividend and positive performance indicators.

Revenue

Cost of revenue

Gross profit

Operating expenses

SG&A

Other

Operating income

EBITDA

Net income

Earnings per share

Total assets

Current assets

Cash & equivalents

Receivables

Inventory

Non-current assets

Net PPE

Intangibles

Total liabilities

Current liabilities

Short term debt

Income tax payable

Non-current liabilities

Long-term debt

Total equity

Stockholders equity

Minority interest

Total liabilities & equity

Total debt

Net debt

Book value per share

Cash from operations

Funds from operations

Change in working capital

Cash from investing

Capital expenditure

Purchase/sale of investments

Purchase/sale of business

Other sources

Cash from financing

Change in stock

Change in debt

Cash dividends paid

Cash from other sources

Net change in cash

Free cash flow

Select Medical Holdings Corp. engages in the provision of medical rehabilitation services. It operates through the following business segments: Critical Illness Recovery Hospital, Rehabilitation Hospital, Outpatient Rehabilitation and Concentra. The Critical Illness Recovery Hospital segment serves patients with debilitating injuries and rehabilitation needs that cannot be adequately cared for in a medically intensive environment, such as a skilled nursing facility. The Rehabilitation Hospital segment provides physical medicine, as well as rehabilitation programs and services, which serve to optimize patient health, function, and quality of life. The Outpatient Rehabilitation segment offers physical, occupational, and speech rehabilitation services through its clinics. The Concentra segment operates through its medical centers and contract services provided at employer worksites and Department of Veterans Affairs community-based outpatient clinics, which deliver occupational medicine, physical therapy, veteran’s healthcare, and consumer health services. The company was founded by Robert A. Ortenzio and Rocco A. Ortenzio in 1996 and is headquartered in Mechanicsburg, PA.

Select Medical (SEM) expects revenues to be within the range of $6.5-$6.7 billion in 2023, indicating a rise of 4.8% from the 2022 figure of $6.3 billion.

Select Medical (SEM) Q1 Earnings Top on Improving Profitability

Select Medical (SEM) came out with quarterly earnings of $0.56 per share, beating the Zacks Consensus Estimate of $0.37 per share. This compares to earnings of $0.37 per share a year ago.

Select Medical (SEM) Q1 Earnings and Revenues Surpass Estimates

MECHANICSBURG, Pa. , May 4, 2023 /PRNewswire/ -- Select Medical Holdings Corporation ("Select Medical," "we," "us," or "our") (NYSE: SEM) today announced results for its first quarter ended March 31, 2023, and the declaration of a cash dividend.

Select Medical Holdings Corporation Announces Results For Its First Quarter Ended March 31, 2023 and Cash Dividend

Select Medical (SEM) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Select Medical (SEM) Reports Next Week: What to Know Ahead of the Release

MECHANICSBURG, Pa. , April 7, 2023 /PRNewswire/ -- Select Medical Holdings Corporation ("Select Medical") (NYSE: SEM), will release the financial results for its first quarter ended March 31, 2023 on Thursday, May 4, 2023 after the market closes.

Select Medical Holdings Corporation to Announce First Quarter 2023 Results on Thursday, May 4, 2023

Select Medical (SEM) acquires the Vibra Hospital of Richmond to provide enhanced critical illness recovery care across Virginia.

Select Medical (SEM) Buys Richmond Post-Acute Care Facility

MECHANICSBURG, Pa. , April 5, 2023 /PRNewswire/ -- Select Medical today announced it has signed an agreement to acquire Vibra Hospital of Richmond, a long-term acute care hospital in Richmond, Virginia.

Select Medical Signs Agreement to Acquire Vibra Hospital of Richmond

Select Medical (SEM) aims to address the post-acute care demand in the Central Florida region through the construction of a specialty hospital in Orlando.

Select Medical's (SEM) Orlando Facility to Boost Post-Acute Care

MECHANICSURG, Pa., March 20, 2023 /PRNewswire/ -- Select Medical today announced plans to build a new specialty hospital to include critical illness recovery and inpatient rehabilitative care in the Dr. Phillips suburb of Orlando, Florida.

Select Medical Announces Plans to Build a New Critical Illness Recovery and Inpatient Rehabilitation Hospital to Serve Greater Orlando

Select Medical (SEM) partners with Lutheran Health Network to enhance critical illness recovery and inpatient rehabilitation services in Fort Wayne and neighborhood communities.

Select Medical (SEM) Forays Into Indiana With Lutheran Health JV

MECHANICSBURG, Pa. and FORT WAYNE, Ind., March 13, 2023 /PRNewswire/ -- Select Medical Corporation (Select Medical) and Lutheran Health Network of Indiana, LLC, a subsidiary of Community Health Systems (CHS) today announced the formation of a joint venture to provide inpatient rehabilitation and critical illness recovery care in Fort Wayne, Indiana.

Select Medical and Lutheran Health Network Partner to Provide Inpatient Rehabilitation and Critical Illness Recovery Post-Acute Care to the Greater Fort Wayne Area

Select Medical (SEM) anticipates 2023 revenues to be within $6.5-$6.7 billion.

Select Medical (SEM) Q4 Earnings Miss Estimates, Revenues Up

Select Medical Holdings Corporation (NYSE:SEM ) Q4 2022 Earnings Conference Call February 24, 2023 9:00 AM ET Company Participants Robert Ortenzio - Executive Chairman and Co-Founder Martin Jackson - EVP and CFO Conference Call Participants Justin Bowers - Deutsche Bank Ben Hendrix - RBC Capital Markets Bill Sutherland - Benchmark Company Miles Highsmith - Deutsche Bank Operator Good morning, and thank you for joining us today for Select Medical Holdings Corporation's Earnings Conference Call to discuss the Fourth Quarter 2022 Results and the Company's Business Outlook. Speaking today are the company's Executive Chairman and Co-Founder, Robert Ortenzio; and the company's Executive Vice President and Chief Financial Officer, Martin Jackson.

Select Medical Holdings Corporation (SEM) Q4 2022 Earnings Call Transcript

Select Medical (SEM) delivered earnings and revenue surprises of -33.33% and 2.35%, respectively, for the quarter ended December 2022. Do the numbers hold clues to what lies ahead for the stock?

Select Medical (SEM) Misses Q4 Earnings and Revenue Estimates

MECHANICSBURG, Pa. , Feb. 23, 2023 /PRNewswire/ -- Select Medical Holdings Corporation ("Select Medical," "we," "us," or "our") (NYSE: SEM) today announced results for its fourth quarter and year ended December 31, 2022 and the declaration of a cash dividend.

Select Medical Holdings Corporation Announces Results For Its Fourth Quarter and Year Ended December 31, 2022 and Cash Dividend

Select Medical's (SEM) fourth-quarter results are likely to reflect improved figures in the Rehabilitation Hospital business.

Select Medical (SEM) to Post Q4 Earnings: What to Expect

Select Medical (SEM) collaborates with AtlantiCare to open an inpatient rehabilitation hospital and jointly manage the operations of SEM's outpatient centers across New Jersey.

Select Medical (SEM) Enters JV to Boost New Jersey Healthcare

MECHANICSBURG, Pa. , Feb. 9, 2023 /PRNewswire/ -- Select Medical Holdings Corporation ("Select Medical") (NYSE: SEM), will release the financial results for its fourth quarter and full year ended December 31, 2022 on Thursday, February 23, 2023 after the market closes.

Select Medical Holdings Corporation to Announce Fourth Quarter and Full Year 2022 Results on Thursday, February 23, 2023

SEM saw several challenges related to OpEx and labor costs in its Q3 results. Despite this, it saw improvements in its agency numbers (rates, utilization) from this time last year.

Select Medical: Retaining Buy Rating Despite Challenging Quarter

Select Medical (SEM) reports improved performance in the Rehabilitation Hospital unit for the third quarter.

Select Medical (SEM) Shares Fall 9.6% Since Q3 Earnings Miss

Select Medical Holdings Corporation (NYSE:SEM ) Q3 2022 Earnings Conference Call November 4, 2022 9:00 AM ET Company Participants Robert Ortenzio - Executive Chairman & Co-Founder Martin Jackson - Executive Vice President & Chief Financial Officer Conference Call Participants Justin Bowers - Deutsche Bank Joanna Gajuk - Bank of America Ben Hendrix - RBC Capital Markets Bill Sutherland - The Benchmark Company Miles Highsmith - Deutsche Bank A.J. Rice - Credit Suisse Operator Good morning and thank you for joining us today for Select Medical Holdings Corporation's Earnings Conference Call to discuss the Third Quarter 2022 Results and the Company's Business Outlook.

Select Medical Holdings Corporation (SEM) Q3 2022 Earnings Call Transcript

Select Medical (SEM) delivered earnings and revenue surprises of -52.27% and 1.14%, respectively, for the quarter ended September 2022. Do the numbers hold clues to what lies ahead for the stock?

Select Medical (SEM) Q3 Earnings Miss Estimates

MECHANICSBURG, Pa. , Nov. 3, 2022 /PRNewswire/ -- Select Medical Holdings Corporation ("Select Medical," "we," "us," or "our") (NYSE: SEM) today announced results for its third quarter ended September 30, 2022, and the declaration of a cash dividend.

Select Medical Holdings Corporation Announces Results For Its Third Quarter Ended September 30, 2022 and Cash Dividend

MECHANICSBURG, Pa. , Oct. 11, 2022 /PRNewswire/ -- Select Medical Holdings Corporation ("Select Medical") (NYSE: SEM), will release the financial results for its third quarter ended September 30, 2022 on Thursday, November 3, 2022 after the market closes.

Select Medical Holdings Corporation to Announce Third Quarter 2022 Results on Thursday, November 3, 2022

Select Medical (SEM) joins forces with UPMC to open its third inpatient rehabilitation hospital in Central Pennsylvania to better address the region's post-acute care needs.

News for Select Medical Holdings Stock (SEM)